Embryos donated to science blow the whistle on CRISPR
By Alison Motluk,
HeyReprotech Newsletter
| 06. 23. 2020
The controversial gene-editing technique mis-snips again. And thanks to embryos donated to science, we know about it.
Many people, finding themselves at the end of their reproductive journey, decide to donate their extra embryos "to science." We don't hear all that much about what becomes of these embryos — what scientific advancements they enabled, what policies they influenced, what practices they helped to curtail.
Here is one such story.
Twenty-five embryos were volunteered into a study using CRISPR, a controversial gene-editing technique. (For a bit of background on the science and politics of CRISPR, see this round-up.) All the couples who donated their embryos gave informed consent. They were told about the research project, were given an opportunity to receive counselling about their decision, and agreed that any results from their contribution could be published in scientific journals. No money changed hands for the embryos.
Some of the findings generated by studying these embryos ended up in one of the world's most prestigious scientific journals, Nature, in this study about the role of a particular gene (POU5F1) in early embryological development.
But those embryos went on to play a role in a second...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...